A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Public ClinicalTrials.gov record NCT07113522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics With Multiple Therapies in Participants With Active Crohn's Disease or Active Ulcerative Colitis (ASCEND-IBD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Study identification
- NCT ID
- NCT07113522
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 140 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 25, 2025
- Primary completion
- Apr 29, 2027
- Completion
- Feb 3, 2028
- Last update posted
- Mar 11, 2026
2025 – 2028
United States locations
- U.S. sites
- 46
- U.S. states
- 20
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mirador Therapeutics Selected Site | Birmingham | Alabama | 35235 | Recruiting |
| Mirador Therapeutics Selected Site | Scottsdale | Arizona | 85258 | Recruiting |
| Mirador Therapeutics Selected Site | Sun City | Arizona | 85351 | Recruiting |
| Mirador Therapeutics Selected Site | Little Rock | Arkansas | 72205 | Recruiting |
| Mirador Therapeutics Selected Site | Little Rock | Arkansas | 72211 | Recruiting |
| Mirador Therapeutics Selected Site | Colorado Springs | Colorado | 80921 | Recruiting |
| Mirador Therapeutics Selected Site | Littleton | Colorado | 80120 | Recruiting |
| Mirador Therapeutics Selected Site | Miami | Florida | 33134 | Recruiting |
| Mirador Therapeutics Selected Site | Miami | Florida | 33165 | Recruiting |
| Mirador Therapeutics Selected Site | Miami | Florida | 33176 | Recruiting |
| Mirador Therapeutics Selected Site | Orlando | Florida | 32825 | Recruiting |
| Mirador Therapeutics Selected Site | Palmetto Bay | Florida | 33176 | Recruiting |
| Mirador Therapeutics Selected Site | Pensacola | Florida | 32504 | Recruiting |
| Mirador Therapeutics Selected Site | Atlanta | Georgia | 30342 | Recruiting |
| Mirador Therapeutics Selected Site | Snellville | Georgia | 30078 | Recruiting |
| Mirador Therapeutics Selected Site | Glenview | Illinois | 60026 | Recruiting |
| Mirador Therapeutics Selected Site | Gurnee | Illinois | 60031 | Recruiting |
| Mirador Therapeutics Selected Site | Lafayette | Louisiana | 70503 | Recruiting |
| Mirador Therapeutics Selected Site | Marrero | Louisiana | 70072 | Recruiting |
| Mirador Therapeutics Selected Site | Shreveport | Louisiana | 71105 | Recruiting |
| Mirador Therapeutics Selected Site | Ypsilanti | Michigan | 48197 | Recruiting |
| Mirador Therapeutics Selected Site | Bridgeton | Missouri | 63044 | Recruiting |
| Mirador Therapeutics Selected Site | Kansas City | Missouri | 64114 | Recruiting |
| Mirador Therapeutics Selected Site | Liberty | Missouri | 64068 | Recruiting |
| Mirador Therapeutics Selected Site | Las Vegas | Nevada | 89128 | Recruiting |
| Mirador Therapeutics Selected Site | New York | New York | 10016 | Recruiting |
| Mirador Therapeutics Selected Site | Rochester | New York | 14618 | Recruiting |
| Mirador Therapeutics Selected Site | High Point | North Carolina | 27262 | Recruiting |
| Mirador Therapeutics Selected Site | Raleigh | North Carolina | 27612 | Recruiting |
| Mirador Therapeutics Selected Site | Cincinnati | Ohio | 45219 | Recruiting |
| Mirador Therapeutics Selected Site | Liberty Township | Ohio | 45044 | Recruiting |
| Mirador Therapeutics Selected Site | Providence | Rhode Island | 02904 | Recruiting |
| Mirador Therapeutics Selected Site | Greenville | South Carolina | 29607 | Recruiting |
| Mirador Therapeutics Selected Site | Cordova | Tennessee | 38018 | Recruiting |
| Mirador Therapeutics Selected Site | Dallas | Texas | 75230 | Recruiting |
| Mirador Therapeutics Selected Site | Garland | Texas | 75044 | Recruiting |
| Mirador Therapeutics Selected Site | Georgetown | Texas | 78628 | Recruiting |
| Mirador Therapeutics Selected Site | Houston | Texas | 77090 | Recruiting |
| Mirador Therapeutics Selected Site | Lubbock | Texas | 79424 | Recruiting |
| Mirador Therapeutics Selected Site | Southlake | Texas | 76092 | Recruiting |
| Mirador Therapeutics Selected Site | Tyler | Texas | 75701 | Recruiting |
| Mirador Therapeutics Selected Site | Webster | Texas | 77598 | Recruiting |
| Mirador Therapeutics Selected Site | Bellevue | Washington | 98004 | Recruiting |
| Mirador Therapeutics Selected Site | Silverdale | Washington | 98383 | Recruiting |
| Mirador Therapeutics Selected Site | Tacoma | Washington | 98405 | Recruiting |
| Mirador Therapeutics Selected Site | Milwaukee | Wisconsin | 53215 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07113522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07113522 live on ClinicalTrials.gov.